Pfizer, Valneva’s experimental Lyme disease vaccine shows 70% efficacy
HQ Team March 25, 2026: Pfizer Inc. and France-based Valneva SE‘s investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals.
Drugs
Medical
Pharma
Drugs
Medical
Pharma
Gilead Sciences to acquire US-based Ouro Medicines for up to $2 billion
Gilead Sciences, Inc., will acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases, for.
Drugs
Medical
Pharma
Novartis AG to buy experimental oral drug of Pikavation for $3 billion
Novartis AG has agreed to buy an investigational oral medicine of Pikavation Therapeutics, a subsidiary of privately-held Synnovation Therapeutics, to treat breast cancer, for.
Health
Medical
Pharma
Roche expands artificial intelligence deployment in pact with Nvidia
Switzerland’s F. Hoffmann-La Roche AG upgraded its artificial intelligence infrastructure by deploying Nvidia’s technology to accelerate development of diagnostic solutions and therapeutics.
Health
Medical
Research
A blood test can reveal your short-term survival period: Study
Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.
Health
Medical
Opinion
Asia’s hidden health crisis: How cultural stereotypes undermine wellness
HQ Staff Writer March 14, 2026: Asia faces a profound health paradox. While medical science advances, rates of non-communicable diseases such as heart.
Medical
Opinion
Research
Dopamine or oxytocin: The neuroscience behind falling in love
Psychologically, love isn't merely an emotion; it's a filter that reshapes our world. In its grip, the brain dials down critical judgment, allowing.
Drugs
Medical
Lowering of criteria for medicine PG challenged in India’s apex court
HQ Team January 16, 2926: In an unprecedented move that has sparked nationwide outrage among medical professionals in India, the National Board of.
Health
Medical
Research
UCL scientists trace Parkinson’s trigger in human brain tissue for first time
University of Cambridge scientists have developed a first-time imaging technique that helps visualise and quantify the early triggers of Parkinson’s — the world’s.
Drugs
Medical
Pharma
US regulator rejects Fortress Biotech’s experimental pediatric medicine
The US regulator has declined to approve an experimental pediatric drug of Fortress Biotech Inc., an American biotechnology company, due to certain production.